Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

9 registered trials, newest registry update first. Showing only trials linked to Retatrutide.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
NCT05936151
RetatrutidePhase 2CompletedEli Lilly and Company146Oct 1, 2025Nov 9, 2026
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
NCT06260722
RetatrutidePhase 3Active not recruitingEli Lilly and Company1,250Aug 27, 2026Sep 28, 2026
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
NCT05929066
RetatrutidePhase 3CompletedEli Lilly and Company2,335Apr 6, 2026Aug 21, 2026
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
NCT05929079
RetatrutidePhase 3CompletedEli Lilly and Company1,152Jun 16, 2026Jul 30, 2026
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
NCT07357415
RetatrutidePhase 3Active not recruitingEli Lilly and Company600Oct 2028Jun 9, 2026
Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
NCT06354660
RetatrutidePhase 3CompletedEli Lilly and Company537Jan 22, 2026Mar 5, 2026
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
NCT05931367
RetatrutidePhase 3CompletedEli Lilly and Company445Nov 14, 2025Jan 21, 2026
A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
NCT04881760
RetatrutidePhase 2CompletedEli Lilly and Company338May 16, 2022Sep 13, 2023
A Study of LY3437943 in Participants With Type 2 Diabetes
NCT04867785
RetatrutidePhase 2CompletedEli Lilly and Company281Jul 8, 2022Jul 3, 2023

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.